SKLAR CORP
10QSB, 2000-02-22
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: FIDELITY MAGELLAN FUND INC, DEFS14A, 2000-02-22
Next: METROPOLITAN EDISON CO, U-1/A, 2000-02-22



                                   FORM 10-QSB
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


(Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
     ACT OF 1934

For the nine month period ended             December 31, 1999

                                       OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

For the transition period from ____________ to ____________

Commission file number        1-6107

                                SKLAR CORPORATION
             (Exact name of registrant as specified in its charter)

        Pennsylvania                                  44-0625447
(State or other jurisdiction of               (I.R.S. Employer Identification
incorporation or organization)                          Number)

889 S. Matlack Street, West Chester, Pennsylvania             19382
(Address of principal executive offices)                   (Zip Code)

Issuer's telephone number                    (610) 430-3200

           Check  whether  the issuer (l) has filed all  reports  required to be
  filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
  preceding  12 months  (or for such  shorter  period  that the  registrant  was
  required  to file  such  reports),  and (2) has been  subject  to such  filing
  requirements for the past 90 days.
                   Yes X                     No ____________

                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

         Check whether the registrant  filed all documents and reports  required
to be  filed  by  Section  12,  13 or  15(d)  of  the  Exchange  Act  after  the
distribution of securities under a plan confirmed by a court.
                   Yes _______               No ________

                      APPLICABLE ONLY TO CORPORATE ISSUERS

         State the number of shares  outstanding of each of the issuer's classes
of common equity, as of the latest practicable date.

                  Class                           Outstanding February 1, 2000
   --------------------------------------        -----------------------------
      (Common stock, $0.10 par value)                      1,104,940

Transitional Small Business Disclosure Format (Check one):  Yes ___   No  X

<PAGE>
                                SKLAR CORPORATION

                                      INDEX
<TABLE>
<CAPTION>
<S>                                                                                      <C>
                                                                                         Page No.

Part I   Financial Information

         Balance Sheet -
                  December 31, 1999 (unaudited) and March 31, 1999 ..........................3

         Statement of Income (Loss) -
                  nine months ended December 31, 1999 and 1998 (unaudited) ..................4

         Statement of Cash Flows -
                  nine months ended December 31, 1999 and 1998 (unaudited) ..................5

         Notes to condensed financial statements ........................................6 - 8

         Management's Discussion and Analysis of Financial
                  Condition and Results of Operations ..................................9 - 11


Part II   Other Information

         Item 1             Legal Proceedings ..............................................11

         Item 3             Defaults Upon Senior Securities ................................11

         Item 5             Other Information ..............................................11

         Item 6             Exhibits and Reports on form 8-K ...............................11
</TABLE>



                                       2
<PAGE>
                                SKLAR CORPORATION
                                  BALANCE SHEET

<TABLE>
<CAPTION>
ASSETS                                                    12/31/99        3/31/99
                                                                        (UNAUDITED)
CURRENT ASSETS:
<S>                                                      <C>            <C>
     Cash                                                $  145,992     $   63,344
     Accounts Receivable                                  2,061,014      1,906,287
     Inventories (Note 5)                                 3,354,223      3,341,331
     Prepaid Expenses                                       222,606        272,652
                                                         ----------     ----------
TOTAL CURRENT ASSETS                                      5,783,835      5,583,614
EQUIPMENT AND IMPROVEMENTS (Note 6)                         664,619        670,708
GOODWILL (Note 7)                                           356,329        439,248
OTHER ASSETS                                                369,846        198,050
                                                         ----------     ----------
TOTAL ASSETS                                             $7,174,629     $6,891,620
                                                         ==========     ==========

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
     Short-term Bank Borrowings (Note 2)                 $  844,000     $  938,000
     Current Portion-Long-Term Debt and
         Capital Lease Obligations                          131,250        132,691
     Trade Accounts Payable                               2,254,478      2,157,953
     Accrued Expenses                                       967,175        809,524
     Accrued Income Taxes                                     9,500          7,658
                                                         ----------     ----------
TOTAL CURRENT LIABILITIES                                 4,206,403      4,045,826

     Long-term Debt and Capital Lease Payable                 5,521         14,538
                                                         ----------     ----------
TOTAL LIABILITIES                                         4,211,924      4,060,364
                                                         ----------     ----------

CONTINGENCIES                                                     0              0

STOCKHOLDERS' EQUITY (Note 9):
     Series A  preferred stock, par value
       $.01 per share, authorized, 35,000 shares;
       24,825 issued  and 22,078 shares outstanding             248            248
     Series A subordinated preferred stock,
       no par value, authorized 4,000 shares; issued
       and outstanding                                            0              0
     Common stock, par value $.10 per share,
        authorized 1,500,000 shares; 1,497,952
        issued, 1,104,940 outstanding                       149,795        149,795
     Additional Paid-in Capital                           2,165,958      2,165,958
     Retained earnings                                      777,742        646,293
                                                         ----------     ----------

                                                          3,093,743      2,962,294
                                                         ----------     ----------

     Less treasury stock                                    131,038        131,038
                                                         ----------     ----------

TOTAL STOCKHOLDER'S EQUITY                                2,962,705      2,831,256
                                                         ----------     ----------

TOTAL LIABILITIES & STOCKHOLDER'S EQUITY                 $7,174,629     $6,891,620
                                                         ==========     ==========
</TABLE>

                        See notes to financial statements

                                       3
<PAGE>
                                SKLAR CORPORATION
                           STATEMENTS OF INCOME (LOSS)
                                   (Unaudited)

<TABLE>
<CAPTION>
<S>                                     <C>                  <C>                  <C>                  <C>
                                                  3 Months Ended                           9 Months Ended
                                           12/31/99            12/31/98             12/31/99             12/31/98
Revenues:
  Net Sales (Note 10)                   $  3,103,749         $  3,529,798         $  9,842,786         $ 10,181,666

Cost and Expenses:
  Cost of Goods Sold                       1,611,577            2,026,993            5,231,463            5,580,016
  Selling, General & Admin                 1,481,565            1,435,866            4,376,831            4,214,180
  Interest                                    26,396               58,945               85,035              164,689
                                        ------------         ------------         ------------         ------------

                                           3,119,538            3,521,804            9,693,329            9,958,885
                                        ------------         ------------         ------------         ------------

  Income/(Loss) before taxes                 (15,789)               7,994              149,457              222,781

Provision for Income Taxes
  Currently Payable (Note 8)                       0                3,104               18,008               32,000
                                        ------------         ------------         ------------         ------------

Net Income                                   (15,789)               4,890              131,449              190,781
                                        ------------         ------------         ------------         ------------

Preferred Dividend
Requirement (Note 9)                          68,994               68,994              206,982              206,982
                                        ------------         ------------         ------------         ------------

Loss Applicable to
Common Shares                                (84,783)             (64,104)             (75,533)             (16,201)
                                        ------------         ------------         ------------         ------------

Per Share Data:

Weighted Average Common Shares
Outstanding
                                           1,104,940              902,766            1,104,940              823,485
                                        ------------         ------------         ------------         ------------

Basic and Diluted Loss Per Share        $      (0.08)        $      (0.07)        $      (0.07)        $      (0.02)
                                        ============         ============         ============         ============
  (Note 11)
</TABLE>


                        See notes to financial statements

                                       4
<PAGE>
                                SKLAR CORPORATION
                            STATEMENTS OF CASH FLOWS
                           INCREASE (DECREASE) IN CASH
                                   (Unaudited)
<TABLE>
<CAPTION>
<S>                                                       <C>                   <C>
                                                               For the Nine Months Ended
                                                            12/31/99              12/31/98

Net Cash Provided by Operating Activities                 $   381,428           $ 1,732,627


Net Cash Provided (Used) by Investing Activities             (194,189)              (49,680)

Net Cash Provided (Used) by Financing Activities             (104,591)           (1,398,937)
                                                          -----------           -----------

Net Increase in Cash                                           82,648               284,010
Cash at Beginning of Period                                    63,344                12,885
                                                          -----------           -----------

Cash at End of Period                                     $   145,992           $   296,895
                                                          ===========           ===========
</TABLE>

                        See notes to financial statements





                                       5
<PAGE>
                                SKLAR CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 1   MANAGEMENT'S REPRESENTATION

In the opinion of Management,  the unaudited  financial  statements  contain all
adjustments  necessary to present  fairly the financial  position as of December
31, 1999 and the results of  operations  and cash flows for the six month period
then ended.

NOTE 2   SHORT-TERM BANK BORROWINGS

On December 4, 1998 the Company  entered into a loan and security  agreement for
$2,000,000,  collateralized by the sum of 80% of qualifying  accounts receivable
plus 50% of inventories.  Borrowings based on eligible  inventories may comprise
up to 50% of the outstanding credit line amount.  Qualifying accounts receivable
and  inventory  used as a basis for the  December  31,  1999  borrowing  totaled
$3,967,653.  Unused  available  credit at December 31, 1999 was  $364,866  after
considering outstanding letters of credit totaling $53,093 and a 20% market risk
reserve on forward currency contracts totaling $159,396.

Borrowings  from this line bear  interest at the Bank's Prime Rate.  At December
31,  1999 the Prime  Rate was 8.5%.  The  interest  expense on  short-term  bank
borrowings  for the nine months  ended  December  31, 1999 and 1998  amounted to
$55,135 and $114,590, respectively.

The full  value of the loan is  guaranteed  personally  by the  Company's  Chief
Financial Officer.

NOTE 3   LONG-TERM DEBT

The  original  contract  under which  Dental  Corporation  of America  (DCA) was
acquired was renegotiated in April 1992. The renegotiated contract,  among other
things, changed the payment terms from three fixed $100,000 annual payments plus
interest and  royalties  based upon future sales to a fixed  monthly  payment of
$12,000 for one year  commencing  April 1, 1992 followed by a monthly payment of
$5,000 for six years commencing April 1, 1993. The gross payments and associated
liability under the new agreement are  substantially  the same as to those which
were recorded,  including  interest,  upon the acquisition of DCA.  Accordingly,
there has been no change to the financial  statements  in  connection  with this
renegotiation.  The new agreement did however  change the aggregate  prospective
maturities.  The Company has not made  payments  against this  obligation  since
September  1996,  but continues to reflect the liability  (See Item 1 (A), Legal
Matters under Part II, Other Information).

NOTE 4   BUSINESS OPERATIONS

The Company  imports and  distributes  under the Sklar,  DCA,  Dittmar and other
trademarks hand-held,  non-electronic  instruments for the surgical,  dental and
veterinary fields.


                                        6

<PAGE>
                                SKLAR CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 4   BUSINESS OPERATIONS, continued

Effective May 31, 1996, the Company  acquired certain assets and assumed certain
liabilities  of  Surgical  Medical  Specialists,  Inc.  (SMS)  in a  transaction
originally valued at $3,306,791.  The purchase price was allocated $1,999,347 to
inventory and  $1,307,444  to goodwill.  The purchase was financed by $1,700,000
drawn  against  the  Company's  then  amended  credit line  agreement,  $900,386
assumption of SMS vendor liabilities,  subject to the agreement, and $706,405 of
notes payable to the seller.  Subsequent to the  acquisition  it was  determined
certain  inventory may have been  misrepresented  or mislabeled and could not be
sold in the United States in accordance with regulations of the U.S. Customs and
Food and Drug Administration.

During the fiscal year ended March 31, 1998,  settlements  were reached with the
seller and one of the vendors included in the original assumed liabilities.  The
settlement  transactions  included a cash payment from the seller, cash payments
to a vendor by the  seller  and a  reduction  of  liabilities  to the seller and
vendors.  These  transactions  were accounted for by an offsetting  reduction of
goodwill.

During the six months ended  September  30, 1998,  an agreement was reached with
another vendor included in the original assumed  liabilities which encompassed a
cash payment of $120,000, in complete satisfaction of liabilities  approximating
$470,000.  This agreement had been recorded at September 30, 1998 as a reduction
of goodwill.

During the quarter ended September 30, 1999, the Company acquired certain assets
of an entity which packages sets of surgical instruments and related supplies in
kit form for resale.  The acquisition amount ($20,000) was assigned to inventory
and to other acquired  assets.  The processes  associated with this  acquisition
will  replace the need to purchase a group of items  previously  purchased  from
third  parties,   thus   increasing   profit  margins  for  that  product  group
prospectively.

NOTE 5   INVENTORIES

Inventories  are  stated at the lower of cost  (first-in,  first-out  method) or
market.

NOTE 6   EQUIPMENT AND IMPROVEMENTS

Equipment and improvements are stated at cost less accumulated  depreciation and
amortization.  Depreciation  and  amortization  are  provided  generally  on the
straight-line  method over the useful lives of the assets which are estimated to
be three to ten years for  equipment and the shorter of the life of the lease or
the life of the asset for leasehold improvements.

NOTE 7   GOODWILL

Goodwill is amortized over fifteen or twenty years.

NOTE 8   INCOME TAXES

Income taxes  represent the State income tax due.  Federal  income taxes payable
are offset by net  operating  loss  carry-forwards.  No tax loss  carry-forwards
exist to offset state income tax payable.


                                       7
<PAGE>
                                SKLAR CORPORATION
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 8   INCOME TAXES, continued

As a  result  of the  merger  of  Medco  Jewelry  Corporation  and  Misdom-Frank
Corporation,  management  believes  there  may be  federal  net  operating  loss
carry-forwards available to Medco Jewelry Corporation at the date of merger that
have transferred to Sklar Corporation.  Such loss  carry-forwards and additional
post-merger operating losses totaling approximately $1,036,000,  which expire in
2000 ($50,000),  2001  ($14,000),  2002  ($461,000),  and 2004  ($511,000),  are
available as deductions from federal taxable income of future years.

NOTE 9   STOCKHOLDERS' EQUITY

As of September 30, 1999, of the  1,500,000  shares of Common Stock  authorized,
1,104,940  were  outstanding.  Of the  Series A  Preferred  Stock,  35,000  were
authorized and 22,078 shares outstanding.

The Series A Preferred  Stock may be redeemed by the Company after March 1, 1986
at a price of $100 per share and is entitled to a liquidation preference of $100
per share plus cumulative dividends. Annual dividends of $12.50 per share accrue
cumulatively on the Series A Preferred Stock commencing on July 1, 1984, payable
on June 30 of each  year  commencing  June 30,  1985.  No  dividends  have  been
declared in the years 1988 through 1999.

The Company filed a preliminary  proxy  statement and a Schedule  13-E3 with the
Commission on January 14, 1999 for the purposed of  effectuating a reverse split
of its common  stock.  If  effected,  it will allow the Company to cease to be a
reporting company under Section 12.

NOTE 10   SALES

Revenue, net of allowance for estimated returns, is recognized upon the shipment
of goods to the customer.

NOTE 11   NET EARNINGS/(LOSS) PER SHARE

Earnings/(loss)  per  share  is  computed  by  dividing  the  net  income/(loss)
applicable to common shares by the weighted  average  number of shares of Common
Stock outstanding after giving effect to the ratably accrued preferred dividend.

NOTE 12   SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

Interest paid amounted to $55,548 in the nine months ended December 31, 1999,
and $127,401 in the nine months ended December 31, 1998.

Income taxes paid amounted to $59,658 in the nine months ended December 31,
1999, and $49,261 in the nine months ended December 31, 1998.

                                       8
<PAGE>
                                SKLAR CORPORATION
                       MANAGEMENT DISCUSSION AND ANALYSIS


The following  discussion and analysis  provides  information  which  management
believes is relevant to an assessment and understanding of the Company's results
of  operations  and  financial  condition.  The  discussion  should  be  read in
conjunction with the financial  statements and notes thereto appearing elsewhere
herein.

RESULTS OF OPERATIONS

The following table sets forth, for the periods indicated, the percentage of net
sales for certain items in the Company's Statements of Income for each period:

Income and Expense Items as Percentage of
Net Sales for the nine months ended December 31

                                     1999                   1998
                                     ----                   ----

Net Sales                            100.0%                100.0%
Cost of Sales                         53.1                  54.8
Gross Profit                          46.9                  45.2
Selling, General and
  Admin. Expenses                     44.5                  41.4
Income Before
  Interest & Taxes                     2.4                   3.8
Interest Expense                       0.9                   1.6
Income Before
  Income Taxes                         1.5                   2.2
Net Income                             1.3                   1.9

SALES

For the three month period ended  December 31, 1999  compared to the  comparable
period ended December 31, 1998, sales decreased  $426,049 or 12.2%. The decrease
in sales is  partially  the result of a single large order  attained  during the
prior period which was not expected to recur during the current  fiscal  period.
For the nine month period ended  December  31, 1999  compared to the  comparable
period in 1998,  sales  decreased  $338,880  or 3.3%.  Management  believes  the
decrease in sales to be the result of diverting their attention to matters other
than sales.  Management  intends to refocus its efforts in the fourth quarter to
improve sales performance.

COST OF SALES

Cost of sales as a percentage of sales for the nine month period ended  December
31, 1999 and 1998  decreased  1.7%.  Changing  product mix would account for the
variation in margin reflected.

                                       9
<PAGE>
                                SKLAR CORPORATION
                       MANAGEMENT DISCUSSION AND ANALYSIS

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Despite a decrease in sales, the Company  continued on its current marketing and
operations plan. Selling, General and Administrative expenses for the nine month
period  ended  December 31, 1999 have  increased  $162,651 or 3.9% from the nine
month period  ended  December  31,  1998.  The Company has made a commitment  to
increased  marketing  and  advertising  effort,   which  resulted  in  increased
advertising and personnel costs. In addition, the Company has made a significant
profit sharing commitment,  thus increasing employee benefits expense. Also, the
Company has incurred  significant  costs  associated  with going private and the
necessary SEC filings that are required.  With the exception of the  SEC-related
costs,  management  expects  to  continue  this level of  expenditure  in future
periods.

INTEREST

Interest  costs  decreased  $79,654  or 48.4% for the nine  month  period  ended
December 31, 1999 compared to the nine month period ended  December 31, 1998 due
to a  reduction  in the  outstanding  line of  credit  and term  debt  funded by
operations and increases in trade accounts payable. In addition, the Company has
experienced  a 1.5%  interest  rate  reduction as the result of the new loan and
security agreement that it entered into in December, 1998.

INCOME TAXES

Federal  income tax  expense is reduced  in both  periods by the  available  net
operating loss  carry-forwards.  Income tax expense  represents the state income
tax payable.

LIQUIDITY AND CAPITAL RESOURCES

The  Company  primarily  funds its  operations  by cash  provided  by  operating
activities. During the nine month period ended December 31, 1999, net income and
non-cash  expenses were the primary  drivers behind cash provided by operations.
Increases  in  accounts  payable  were  offset by a net  increase in prepaid and
accrued expenses.  Additionally,  increases in accounts receivable and inventory
reduced cash available by approximately $165,000.

In  the  comparative  nine  month  period  a  significant  decline  in  accounts
receivable   ($312,000)   and  a  significant   increase  in  accounts   payable
($1,120,000)  combined  with the net income of $266,000 and non cash expenses to
produce an operating cash flow of $1,732,000.

Cash on hand,  expected future cash flow from  operations and amounts  available
under the current bank  facility are  considered  to be  sufficient  to meet the
company's liquidity needs in the foreseeable future.


                                       10
<PAGE>
                           PART II - OTHER INFORMATION

ITEM 1   LEGAL MATTERS

The Company filed suit in 1992 against the former principal of DCA for violating
the  terms  of a  non-compete  agreement  signed  as  part  of  a  re-negotiated
settlement for the purchase of DCA. The suit seeks the return of all monies paid
to the former  principal.  The case is  currently  under  appeal to the Superior
Court of Pennsylvania and no assessment of the outcome of the case has been made
by  counsel.  Payments  for  DCA  have  been  suspended  since  September  1996.
Settlement  negotiations  are currently  ongoing and a  satisfactory  outcome is
anticipated but the remaining liability is still recorded.

The  Company  filed  suit in the  Court of  Common  Pleas  for  Chester  County,
Pennsylvania against an entity known as "Endo-Surgical  Systems,  Inc." ("ENDO")
in February of 1998. Endo is controlled by the Company's former Controller.  The
suit  alleges  misappropriation  of  trade  secrets  and  conversion,   tortious
interference with existing contractual relations, and tortious interference with
prospective  economic  advantage.  Injunctive  relief is sought in  addition  to
damages,  costs,  and fees.  In December of 1997,  the Company also filed in the
court of Common Pleas for Chester  County,  a Writ of Summons against the former
controller, personally. The Company then conducted a fact-finding effort and, as
a result,  a complaint was filed in May of 1998.  The complaint  alleges,  among
other things,  that the former  Controller has violated the standards of conduct
in the practice of public  accounting and engaged in  misappropriation  of trade
secrets  and   conversion,   breach  of   fiduciary   duties  and   confidential
relationship,  tortious  interference with existing  contractual  relationships,
tortious interference with prospective economic advantage,  defamation and trade
libel, breach of contract, and fraud and  misrepresentation.  Injunctive relief,
damages,  costs and fees are sought but the aggregate  amount is not  considered
material.  Defendants in both cases have filed counter claims and the litigation
is  ongoing.  In  September,  the  scope  of  the  lawsuit  against  Wilson  was
substantially reduced. The company and Counsel believe that they will prevail on
all  remaining  issues.  Due to  the  failure  of the  parties  to  arrive  at a
settlement, the trial has been scheduled for March 20, 2000.

ITEM 3   DEFAULTS UPON SENIOR SECURITIES

As disclosed  in Note 9 to the  financial  statements,  the  registrant  did not
declare a dividend on its cumulative  Series A Preferred  Stock on June 30, 1988
through 1999.

ITEM 5   OTHER INFORMATION

The Company filed a preliminary  proxy  statement and a Schedule  13-E3 with the
Commission on January 14, 1999 for the purposed of  effectuating a reverse split
of its common  stock.  If  effected,  it will allow the company to cease to be a
reporting  company under section 12. A special meeting of  shareholders  will be
held for the purpose of voting on the reverse  split  proposal.  No date has yet
been set.

ITEM 6    EXHIBITS AND REPORTS ON FORM 8-K

(b) No  reports on Form 8-K have been filed  during the  quarter  for which this
report is filed.




                                       11
<PAGE>
                                    SIGNATURE


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  the  report  to be  signed  on its  behalf  by the
undersigned thereunto duly authorized.



SKLAR CORPORATION


/S/Michael Malinowski
MICHAEL MALINOWSKI
CHIEF FINANCIAL OFFICER

February 22, 2000


<TABLE> <S> <C>

<ARTICLE>      5
     <CIK>     0000064500
     <NAME>    SKLAR CORPORATION

<S>                             <C>
<PERIOD-TYPE>                             9-MOS
<FISCAL-YEAR-END>                   MAR-31-2000
<PERIOD-END>                        DEC-31-1999
<CASH>                                  145,992
<SECURITIES>                                  0
<RECEIVABLES>                         2,163,436
<ALLOWANCES>                            102,422
<INVENTORY>                           3,354,223
<CURRENT-ASSETS>                      5,783,835
<PP&E>                                1,715,402
<DEPRECIATION>                        1,050,783
<TOTAL-ASSETS>                        7,174,629
<CURRENT-LIABILITIES>                 4,206,403
<BONDS>                                       0
                         0
                                 248
<COMMON>                                149,795
<OTHER-SE>                            2,812,662
<TOTAL-LIABILITY-AND-EQUITY>          7,174,629
<SALES>                               9,842,786
<TOTAL-REVENUES>                      9,842,786
<CGS>                                 5,231,463
<TOTAL-COSTS>                         9,608,294
<OTHER-EXPENSES>                              0
<LOSS-PROVISION>                              0
<INTEREST-EXPENSE>                       85,035
<INCOME-PRETAX>                         149,457
<INCOME-TAX>                             18,008
<INCOME-CONTINUING>                     131,449
<DISCONTINUED>                                0
<EXTRAORDINARY>                               0
<CHANGES>                                     0
<NET-INCOME>                            131,449
<EPS-BASIC>                               (0.07)
<EPS-DILUTED>                             (0.07)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission